Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3

References

• KelsenDPWinterKAGundersonLLLong-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancerJ Clin Oncol200725243719372517704421
   PubMed Web of Science ®Google Scholar
• PottgenCStuschkeMRadiotherapy versus surgery within multimodality protocols for esophageal cancer--a meta-analysis of the randomized trialsCancer Treat Rev201238659960422116018
   PubMed Web of Science ®Google Scholar
• CooperJSGuoMDHerskovicAChemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology GroupJAMA1999281171623162710235156
   PubMed Web of Science ®Google Scholar
• GoodJSHarringtonKJThe hallmarks of cancer and the radiation oncologist: updating the 5Rs of radiobiologyClin Oncol (R Coll Radiol)2013251056957723850153
   PubMed Web of Science ®Google Scholar
• JezJMBennettMJSchlegelBPLewisMPenningTMComparative anatomy of the aldo-keto reductase superfamilyBiochem J1997326Pt 36256369307009
   PubMedGoogle Scholar
• LabrieFLuu-TheVLinSXIntracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and diseaseJ Mol Endocrinol200025111610915214
   PubMed Web of Science ®Google Scholar
• LinHKJezJMSchlegelBPPeehlDMPachterJAPenningTMExpression and characterization of recombinant type 2 3 alpha-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellular distributionMol Endocrinol19971113197119849415401
   PubMedGoogle Scholar
• XiongWZhaoJYuHElevated expression of AKR1C3 increases resistance of cancer cells to ionizing radiation via modulation of oxidative stressPLoS One2014911e11191125419901
   PubMed Web of Science ®Google Scholar
• SunSQGuXGaoXSOverexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiationOncotarget2016730480504805827385003
   PubMedGoogle Scholar
• DaviesNJHaydenRESimpsonPJAKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effectsCancer Res200969114769477519487289
   PubMed Web of Science ®Google Scholar
• KimJHLeeSYOhSYMethyl jasmonate induces apoptosis through induction of Bax/Bcl-XS and activation of caspase-3 via ROS production in A549 cellsOncol Rep20041261233123815547743
   PubMed Web of Science ®Google Scholar
• OhSYKimJHParkMJInduction of heat shock protein 72 in C6 glioma cells by methyl jasmonate through ROS-dependent heat shock factor 1 activationInt J Mol Med200516583383916211252
   PubMed Web of Science ®Google Scholar
• DesmondJCMountfordJCDraysonMTThe aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugsCancer Res200363250551212543809
   PubMed Web of Science ®Google Scholar
• PengZZhangYMethyl jasmonate induces the apoptosis of human colorectal cancer cells via downregulation of EZH2 expression by microRNA101Mol Med Rep201715295796228000868
   PubMed Web of Science ®Google Scholar
• ZhangMSuLXiaoZLiuXLiuXMethyl jasmonate induces apoptosis and pro-apoptotic autophagy via the ROS pathway in human non-small cell lung cancerAm J Cancer Res20166218719927186395
   PubMed Web of Science ®Google Scholar
• FingrutOReischerDRotemRJasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cellsBr J Pharmacol2005146680080816170329
   PubMed Web of Science ®Google Scholar
• JezJMFlynnTGPenningTMA new nomenclature for the aldo-keto reductase superfamilyBiochem Pharmacol19975466396479310340
   PubMed Web of Science ®Google Scholar
• ParkALLinHKYangQDifferential expression of type 2 3alpha/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous systemInt J Clin Exp Pathol20103874375421151387
   PubMed Web of Science ®Google Scholar
• AzzarelloJTLinHKGherezghiherAExpression of AKR1C3 in renal cell carcinoma, papillary urothelial carcinoma, and Wilms’ tumorInt J Clin Exp Pathol20093214715520126582
   PubMed Web of Science ®Google Scholar
• ChangTSLinHKRogersKAExpression of aldo-keto reductase family 1 member C3 (AKR1C3) in neuroendocrine tumors & adenocarcinomas of pancreas, gastrointestinal tract, and lungInt J Clin Exp Pathol20136112419242924228104
   PubMed Web of Science ®Google Scholar
• MillerVLLinHKMuruganPAldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinomaInt J Clin Exp Pathol20125427828922670171
   PubMed Web of Science ®Google Scholar
• PenningTMBurczynskiMEJezJMHuman 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormonesBiochem J2000351Pt 1677710998348
   PubMedGoogle Scholar
• MatsuuraKShiraishiHHaraAIdentification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activityJ Biochem199812459409469792917
   PubMed Web of Science ®Google Scholar
• ShiibaMYamagamiHYamamotoAMefenamic acid enhances anticancer drug sensitivity via inhibition of aldo-keto reductase 1C enzyme activityOncol Rep20173742025203228259989
   PubMed Web of Science ®Google Scholar
• LiuCArmstrongCMLouWLombardAEvansCPGaoACInhibition of AKR1C3 activation overcomes resistance to abiraterone in advanced prostate cancerMol Cancer Ther2017161354427794047
   PubMed Web of Science ®Google Scholar
• AhmadPRasoolSGulAJasmonates: multifunctional roles in stress toleranceFront Plant Science20167813
   PubMedGoogle Scholar
• WangJJMakOTInduction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARgamma activation in non-small cell lung carcinoma A549 cellsProstaglandins Other Lipid Mediat2011943–410411121396480
   PubMed Web of Science ®Google Scholar
• KniazhanskiTJackmanAHeyfetsAGonenPFlescherEShermanLMethyl jasmonate induces cell death with mixed characteristics of apoptosis and necrosis in cervical cancer cellsCancer Lett20082711344618599197
   PubMed Web of Science ®Google Scholar
• WangYXiangWWangMMethyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101Br J Pharmacol2014171361863524490857
   PubMed Web of Science ®Google Scholar
• ZhengLLiDXiangXMethyl jasmonate abolishes the migration, invasion and angiogenesis of gastric cancer cells through down-regulation of matrix metalloproteinase 14BMC Cancer2013137423394613
   PubMed Web of Science ®Google Scholar
• HeyfetsAFlescherECooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-D-glucoseCancer Lett2007250230031017125916
   PubMed Web of Science ®Google Scholar
• MilrotEJackmanAFlescherEEnhanced killing of cervical cancer cells by combinations of methyl jasmonate with cisplatin, X or alpha radiationInvest New Drugs201331233334422956285
   PubMed Web of Science ®Google Scholar
• EzekwudoDShashidharamurthyRDevineniDBozemanEPalaniap-panRSelvarajPInhibition of expression of anti-apoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line (PC-3) by methyl jasmonateCancer Lett2008270227728518573594
   PubMed Web of Science ®Google Scholar
• FormanBMTontonozPChenJBrunRPSpiegelmanBMEvansRM15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gammaCell19958358038128521497
   PubMed Web of Science ®Google Scholar
• KliewerSALenhardJMWillsonTMPatelIMorrisDCLehmannJMA prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiationCell19958358138198521498
   PubMed Web of Science ®Google Scholar
• MichalikLDesvergneBWahliWPeroxisome-proliferator-activated receptors and cancers: complex storiesNat Rev Cancer200441617014708026
   PubMed Web of Science ®Google Scholar
• MichalikLWahliWPPARs Mediate lipid signaling in inflammation and cancerPPAR Res2008200813405919125181
   PubMed Web of Science ®Google Scholar
• KumarPBaruaCCSulakhiyaKSharmaRKCurcumin ameliorates cisplatin-induced nephrotoxicity and potentiates its anticancer activity in SD rats: potential role of curcumin in breast cancer chemotherapyFront Pharmacol2017813228420987
   PubMed Web of Science ®Google Scholar
• GaoSWuRZengYUp-regulation of peroxisome proliferator-activated receptor gamma in radiation-induced heart injury in ratsRadiat Environ Biophys2012511535921997460
   PubMed Web of Science ®Google Scholar
• TachibanaKYamasakiDIshimotoKDoiTThe role of PPARs in cancerPPAR Res2008200810273718584037
   PubMed Web of Science ®Google Scholar
• LeaMASuraMDesbordesCInhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) gamma agonists and antagonistsAnticancer Res2004245a2765277115517883
   PubMed Web of Science ®Google Scholar
• KeshamouniVGReddyRCArenbergDAPeroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancerOncogene200423110010814712215
   PubMed Web of Science ®Google Scholar
• WickMHurteauGDessevCPeroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growthMol Pharmacol20026251207121412391285
   PubMed Web of Science ®Google Scholar
• KimKYKimSSCheonHGDifferential anti-proliferative actions of peroxisome proliferator-activated receptor-gamma agonists in MCF-7 breast cancer cellsBiochem Pharmacol200672553054016806087
   PubMed Web of Science ®Google Scholar
• MantelACarpenter-MendiniAVanBuskirkJPentlandAPAldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolismExp Dermatol201423857357824917395
   PubMed Web of Science ®Google Scholar
• KimREmiMTanabeKMurakamiSUchidaYArihiroKRegulation and interplay of apoptotic and non-apoptotic cell deathJ Pathol2006208331932616261658
   PubMed Web of Science ®Google Scholar
• SpitzDRAzzamEILiJJGiusDMetabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biologyCancer Metastasis Rev2004233–431132215197331
   PubMed Web of Science ®Google Scholar
• DiehnMChoRWLoboNAAssociation of reactive oxygen species levels and radioresistance in cancer stem cellsNature2009458723978078319194462
   PubMed Web of Science ®Google Scholar